Development
Predictmedix AI Inc.
PMED
CNSX
| 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -87.18% | -93.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -87.18% | -93.55% |
| Cost of Revenue | -- | -- | -- | -100.00% | -- |
| Gross Profit | -- | -- | -- | -83.01% | -90.33% |
| SG&A Expenses | -3.84% | 95.93% | 65.76% | 67.58% | -11.63% |
| Depreciation & Amortization | 0.65% | 0.64% | 5.10% | -49.92% | 6,040.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.40% | 84.81% | 52.88% | 42.76% | -6.47% |
| Operating Income | 2.64% | -87.69% | -65.44% | -50.65% | -4.67% |
| Income Before Tax | 4.11% | -79.34% | -43.51% | -39.60% | 6.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 4.11% | -79.34% | -43.51% | -39.60% | 6.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.11% | -79.34% | -43.51% | -39.60% | 6.35% |
| EBIT | 2.64% | -87.69% | -65.44% | -50.65% | -4.67% |
| EBITDA | 2.82% | -89.78% | -88.77% | -53.08% | -2.57% |
| EPS Basic | 26.67% | -37.04% | -17.39% | -24.44% | 11.76% |
| Normalized Basic EPS | 26.32% | -35.29% | -21.43% | -25.00% | 9.52% |
| EPS Diluted | 26.67% | -37.04% | -17.39% | -24.44% | 11.76% |
| Normalized Diluted EPS | 26.32% | -35.29% | -21.43% | -25.00% | 9.52% |
| Average Basic Shares Outstanding | 26.93% | 28.59% | 22.00% | 12.06% | 7.06% |
| Average Diluted Shares Outstanding | 26.93% | 28.59% | 22.00% | 12.06% | 7.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |